Q4 2025 Management View John Larson, President and CEO, stated, "Since stepping into the CEO role in 2025... we have focused on executing a product-led turnaround while building a structurally leaner, ...

PARIS--(BUSINESS WIRE)--Enterprises in France are facing competing pressures, prompting them to reassess their public cloud investments to balance the need for AI-driven innovation and cost ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In 2022, the Biden Administration enacted the Inflation Reduction ...

PepsiCo, Inc.’s PEP 2025 strategy hinges on a simple equation: aggressive cost reduction and an accelerated innovation agenda. After a period of margin pressure caused by inflation, higher global ...

The National Institutes of Health has made a landmark decision that could irreparably damage the backbone of American scientific innovation: a dramatic reduction in the indirect cost rate for research ...

The Biden administration’s newly announced negotiated lower prices for the 10 most expensive drugs covered by Medicare are expected to have significant consequences for research and development as ...

As pressure to reduce costs increases, CFOs have an opportunity to deepen their cross-functional influence and fortify their advisory role to the CEO and other C-suite leaders. Capitalizing on this ...

Why do some climate innovations fail to deliver? Not because they’re flawed, but because the business world misjudges their economics. From hydrogen to EV infrastructure, carbon-capture startups to ...

The authors explore the economic impact and accessibility challenges of new Alzheimer disease drugs under the Inflation Reduction Act, with emphasis on Medicare, pricing, and health care equity.

France’s enterprises torn by competing pressures to adopt GenAI, optimize cloud costs and navigate Europe’s economic challenges, ISG Provider Lens™ report says PARIS--(BUSINESS WIRE)-- Enterprises in ...